Check out the companies making headlines yesterday: PacBio (NASDAQ:PACB): Genomics company Pacific Biosciences of California (NASDAQ:PACB) rose by 5.8% on Mo...
What Happened? Shares of medical technology company Teleflex (NYSE:TFX) jumped 4.5% in the afternoon session after BofA Securities upgraded the stock from Ne...
Even though Teleflex (currently trading at $122.08 per share) has gained 6.2% over the last six months, it has lagged the S&P 500’s 21.4% return during that ...
Looking back on surgical equipment & consumables - specialty stocks’ Q2 earnings, we examine this quarter’s best and worst performers, including Teleflex (NY...
Unprofitable companies can burn through cash quickly, leaving investors exposed if they fail to turn things around. Without a clear path to profitability, th...
Teleflex’s second quarter was marked by revenue and non-GAAP earnings per share above Wall Street expectations, yet the operating margin declined significant...
Many small-cap stocks have limited Wall Street coverage, giving savvy investors the chance to act before everyone else catches on. But the flip side is that ...
Teleflex (NYSE:TFX) reported second-quarter revenue and adjusted earnings above its expectations, supported by strong growth in its Vascular and Surgical businesses, while slower-than-anticipated integration of its acquired Vascular Intervention business weighed on Interventional results.
Revenue f
Medical technology company Teleflex (NYSE:TFX) reported Q2 CY2026 results exceeding the market’s revenue expectations, with sales up 28.9% year on year to $5...
Medical technology company Teleflex (NYSE:TFX) will be reporting earnings this Thursday morning. Here’s what to expect. Teleflex beat analysts’ revenue expec...
Running at a loss can be a red flag. Many of these businesses face mounting challenges as competition increases and funding becomes harder to secure. Finding...
Wrapping up Q1 earnings, we look at the numbers and key takeaways for the surgical equipment & consumables - specialty stocks, including Teleflex (NYSE:TFX) ...
Teleflex trades at $132.09 per share and has stayed right on track with the overall market, gaining 9.6% over the last six months. At the same time, the S&P ...
Teleflex’s first quarter was marked by substantial year-on-year revenue growth, which outpaced Wall Street’s expectations and triggered a significant positiv...
Medical technology company Teleflex (NYSE:TFX) reported Q1 CY2026 results exceeding the market’s revenue expectations, with sales up 32.3% year on year to $5...
What Happened? Shares of medical technology company Teleflex (NYSE:TFX) jumped 9.2% in the afternoon session after the company reported first-quarter 2026 fi...
Medical technology company Teleflex (NYSE:TFX) reported Q1 CY2026 results beating Wall Street’s revenue expectations, with sales up 32.3% year on year to $54...
Medical technology company Teleflex (NYSE:TFX) will be reporting earnings this Thursday morning. Here’s what investors should know. Teleflex missed analysts’...
Wall Street has issued downbeat forecasts for the stocks in this article. These predictions are rare - financial institutions typically hesitate to say bad t...
